The Effects of a 6-week Pre-operative Administration of a Microbiome Modulator "WellBiome" Versus Placebo on Cardiac Surgical Outcomes and NHS Cost Savings.

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age50-80
SponsorHull University Teaching Hospitals NHS Trust

About this trial

More than 7.4 million people in the UK are currently waiting for surgery. Behind that number are real people-patients preparing mentally and physically for procedures ranging from joint replacements to major heart and abdominal operations.

This research forms part of a broader strategy known as prehabilitation - preparing the body before surgery to improve outcomes afterward. For patients waiting for surgery, it represents a shift from passive waiting to active preparation.

Heart surgery for bypass or valve replacements results in inevitable yet controlled trauma. It increases inflammation, stress hormones and immune system demand. The body then has to repair itself - quickly and efficiently. And here's the surprising part. Inside your gut live trillions of bacteria - called your gut microbiome. These bacteria help regulate inflammation, strengthen your immune system and protect against infection.

This randomised clinical trial is investigating a fascinating question:

Can improving your gut microbiome through consumption of fibre before surgery help you recover faster, reduce time in ICU, shorten hospital stays, and lower complication rates? The placebo controlled trial will randomise 80 patients following eligibiilty checks to either 5g of prebiotic fibre/300mg of magnesium (WellBiome) OR 5g of maltodextrin for a period of 6-8 weeks prior to surgery. Patient will provide blood, urine and faecal samples at baseline and upon admission for surgery, and two further blood samples at day 3 and 6 post operatively.

Following surgery, patient outcomes will be assessed and compared between the experimental group (prebiotic fibre/magnesium) and placebo group (maltodextrin). The investigators are focussing on the time spent in the intensive care unit, complications and overall hospital stay. By documenting and quantifying these the investigators can calculate the costs and any savings between the groups.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Aged 50-80

BMI ≥ 25-40kg/m²

Waist circumference >94cm (men) and 88cm (women)

HbA1c 42-58 mmol/mol (6.0-7.5 old HbA1c units)

Disqualifiers

Active cancer

Any gastro-intestinal surgery or currently under the care of the GI clinical team for any clinically significant digestive issue (Crohn's, IBS, ulcerative colitis).

On or had antibiotic treatment in the last 3 months.

Patients who have taken ibuprofen in the last week or any condition that increases the likelihood of regular or sustained use during the intervention.

Trial design

Design model

Parallel

Treatments tested in this trial

  • 5g of prebiotic fibre and 300mg of magnesium (WellBiome)

    Dietary supplement

    5g of prebiotic fibre and 300mg of magnesium (WellBiome)

  • 5g of maltodextrin

    Dietary supplement

    A matched placebo of 5g maltodextrin

Treatment groups

80 Participants
are divided into 2 treatment groups
Group A: PlaceboPlacebo comparator 1 intervention
Group B: ExperimentalExperimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

ICU time (hours)

1\. Time in ICU (hours) The total time in hours spent in the ICU, calculated from ICU admission following cardiac surgery to ICU discharge to the general cardiology ward

Time frame
From ICU admission until ICU discharge, up to 30 days
2

Complications post cardiac surgery

The number of Society of Cardio-thoracic Surgery register of complications

Time frame
Number of complications following cardiac surgery, up to 30 days.
3

Length of hospital stay (days)

Length of hospital stay from admission to medical discharge

Time frame
From hospital admission until hospital discharge, up to 30 days

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.